Welcome To The Mannkind HUB On AGORACOM

Edit this title from the Fast Facts Section

Free
Message: Shkreli still short it appears - POS

lol he went from no chance it will be approved to "a small chance it will have commercial success. " He doesn't acknoweldge other users alledging his "Eval of prev trial data was wrong, non-infrty vs superiority" on twitter either. He seems quiet to me now compaed to before. haha

Shkreli Evaluation

Share
New Message
Please login to post a reply